Author

Mingyi Zhao

Institutions: Shenyang Pharmaceutical University, Central South University, Third Xiangya Hospital

Observed institutions: Shenyang Pharmaceutical University, Central South University, Third Xiangya Hospital

ORCID: 0000-0002-6723-0957

Observed ORCID: 0000-0002-6723-0957

OpenAlex ID: A5065949798

Gangliosides play important roles in the nervous system by regulating ion concentrations

2022 · Yijia Xu, Jianfang Sun, et al. · Neurochemical Research · 18

Butein, a potential drug for the treatment of bone cancer pain through bioinformatic and network pharmacology

2023 · Xin Liu, Shangfeng Zhao, et al. · Toxicology and Applied Pharmacology · 10

Identification of anoikis-related gene signatures and construction of the prognosis model in prostate cancer

2024 · Wanying Kang, Chen Ye, et al. · Frontiers in Pharmacology · 4

CFTR-driven immune microenvironment reprogramming synergizes with anti-PD-L1 antibody in hepatocellular carcinoma

2026 · Yijia Xu, Jianfang Sun, et al. · Cell Death and Disease · 1

Analysis of intratumoural bacteria: Opportunities and challenges for cancer therapy

2026 · Xiaowen Jiang, Chunyan Zhang, et al. · Acta Pharmaceutica Sinica B · 1

Comparing the Efficacy of Various Treatment Strategies for Patients With Advanced Triple‐Negative Breast Cancer: An Umbrella Review

2026 · Xiaolan Ma, Shubing Jia, et al. · Clinical Pharmacology & Therapeutics · 1

Role of basic chemistry education in clinical pharmacy requirements: evidence from cross-sectional study and narrative review

2026 · Yingshi Zhang, Ziang Xu, et al. · BMC Medical Education · 1

Research focus and thematic trends of transient receptor potential vanilloid member 1 research: a bibliometric analysis of the global publications (1990–2023)

2023 · Xin Liu, Mengying Zhang, et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 1

Global trends and knowledge mapping of steroid-resistant nephrotic syndrome research: a bibliometric analysis

2026 · Lin Hu, Mingyi Zhao, et al. · Naunyn-Schmiedeberg s Archives of Pharmacology

Peptide inhibitors of immune checkpoints: Bridging the gap toward next-generation cancer immunotherapy

2026 · Shan Gao, Zhengyu Li, et al. · Critical Reviews in Oncology/Hematology

Butein, a potential drug for the treatment of Bone Cancer Pain through bioinformatic and network pharmacology

2022 · Liu Xin, Shangfeng Zhao, et al. · Research Square

CFTR, one membrane protein, inhibits proliferation and metastasis of hepatocellular carcinoma through new pathways

2022 · Yijia Xu, Liying Yang, et al. · Research Square

Works count: 12

Citation count: 36

H-index: 3

I10-index: 2